Trifecta receptor activation promotes balance.

Retatrutide (GLP-1 R)

Peptide Class

Triple Agonist Peptide

Primary Benefit

Metabolism Boost

Suggested Dose

2-12 mg

Dose Frequency

Once per week

Administration Method

Subcutaneous

Notes

Same day every week | Starting does is 2 mg

Course Description

Retatrutide is a next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors for superior weight loss and metabolic enhancement. This course explores its impact on appetite control, glucose regulation, and energy balance, making it a powerful tool for obesity and metabolic health management.

Key Learnings

Understand how Retatrutide's triple agonist mechanism works.
Explore its benefits in weight loss and fat metabolism.
Learn about its effects on glucose control and insulin sensitivity.
Examine research supporting its effectiveness in obesity management.
Analyze its role in improving energy expenditure and metabolic rate.
Discover how it compares to other GLP-1 receptor agonists.

Who Is This Course For?

This course is designed for healthcare providers, obesity researchers, and individuals looking to optimize metabolic health. Whether you're exploring weight loss solutions or managing diabetes, this course provides cutting-edge knowledge on Retatrutide.